Back

Implementing dynamic atrioventricular delay optimization for cardiac resynchronization therapy: an economic analysis in the EU5 countries.

1 September 2024 (17:00 - 17:50)
Organised by: Logo
Congress Presentation Part of: Exploring cardiovascular health: lifestyle, economics, and disparities Health Economics ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Thiemo Kellmann

Brussels (Belgium)

7 More presentations in this session

Presentation thumbnail
Association between life's essential 8 score and 5-year all-cause and cardiovascular mortality in people with prediabetes: based on a cohort study
Doctor X. Li (Kunming, CN)
Abstract Slides Video
Presentation thumbnail
Physical activity habits among members of the Athens Medical Society in Greece
Doctor E. Oikonomou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Weekend compensatory sleep is associated with reduced risk of heart disease: a prospective UK Biobank-based cohort study
Mr Y. Song (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
The association between the dietary salt intake and glucose intolerance in healthy populations: from the Korean National Health and Nutritional Examination Survey (KNHANES)
Miss S. Hyun (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Health inequities in cardiac care and cardiovascular guideline concordance in Australian migrant populations: data correlation for culturally and linguistically diverse populations (DatCALD) project
Associate Professor K. Wechkunanukul (Adelaide, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Exploring cardiovascular health: lifestyle, economics, and disparities

The Event

Event poster

ESC Congress 2024

1 September 2024 17:00 CET
You may be interested in
thumbnail
Congress Presentation
Clinical and economic impact of a dynamic atrioventricular optimization algorithm for cardiac resynchronization therapy on QRS duration
thumbnail
Congress Presentation
Economic Toll of Cardiovascular Disease on Healthcare and Mortality in 50 ESC member countries
thumbnail
Congress Presentation
A value-based analysis of the systematic use of dapagliflozin in patients with heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources